4 reports

  • Deal in Brief
  • Deal Type

GlobalData OBI Pharma Inc' s, deal volume increased from one pharmaceuticals & healthcare deal in 2016 to two pharmaceuticals & healthcare deals in 2017.

  • Cancer
  • Healthcare
  • Taiwan
  • M&A
  • OBI Pharma, Inc.
  • PARTNERSHIPS
  • ASSET PURCHASE

The company reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Cancer
  • Pharmaceutical
  • Taiwan
  • Company
  • Senhwa Biosciences, Inc.
  • MEDIGENE ENTERS INTO LICENSING AGREEMENT WITH SYNCORE BIOTECHNOLOGY FOR ENDOTAG-1

EndoTAG-##, a novel composition of cytostatic drug paclitaxel combined with neutral and positive lipids used for the treatment of triple-negative breast cancer (TNBC) and pancreatic cancer.

  • Cancer
  • Healthcare
  • Pharmaceutical
  • Taiwan
  • Sinphar Pharmaceutical Co., Ltd.
  • PHARMAENGINE INC, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS
  • LICENSING AGREEMENTS

Cash (US$ m) Deal Rationale Deal Information Deal Status Completed Date Deal Financials Deal Value (US$ m) Upfront Payment (US$ m) Milestone Payment (US$ m) Deal Product NBTXR-##_ Completed ##-Aug-2012 Product Description ## ## ## ## Companies Information Licensor Company Information

  • Cancer
  • Pathology
  • Taiwan
  • Deals & Alliance
  • PharmaEngine, Inc.